Risk of herpes zoster associated with JAK inhibitors in immune-mediated inflammatory diseases: a systematic review and network meta-analysis
Objective: Janus kinase (JAK) inhibitors are a novel class of drugs that have shown efficacy in treating immune-mediated inflammatory diseases (IMIDs). However, their safety profile in terms of herpes zoster infection remains unclear. We aimed to evaluate the risk of herpes zoster associated with JA...
Saved in:
Main Authors: | Qingling Xu (Author), Liyuan He (Author), Yufeng Yin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Herpes Zoster
by: Hamid Ehsani-Nia, et al.
Published: (2017) -
Studies with herpes zoster vaccines in immune compromised patients
by: Myron J. Levin, et al.
Published: (2017) -
Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysis
by: Jiaxing Chen, et al.
Published: (2024) -
The Effectiveness of Acupuncture for Herpes Zoster: A Systematic Review and Meta-Analysis
by: Seong-Kyeong Choi, et al.
Published: (2023) -
Clinical Study of Herpes Zoster In children CLINICAL STUDY OF HERPES ZOSTER IN CHILDREN
by: REYSAN MEHDI DAGHER
Published: (2020)